ATLANTA--(BUSINESS WIRE)--UCB, a leading biopharmaceutical company at the forefront of immunology treatment and research, is marking the 2011 American College of Rheumatology (ACR) meeting by reinforcing its commitment to people living with rheumatoid arthritis (RA) and their healthcare providers. At this year’s ACR meeting, UCB is proud to sponsor several key sets of data with new findings on patient-reported quality of life measures, including work and household productivity, as well as other clinical response measures.
